Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftazidime-sulbactam vs cefoperazone-sulbactam in respiratory and urinary infections
CTR20132859Phase 2Active
- Sponsor
- Xiangbei Welman Pharmaceuticals
- Start
- Mar 2014
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 2 trial of ceftazidime + sulbactam in pneumonia, acute bronchitis, chronic bronchitis (CB), bronchiectasis, chronic obstructive pulmonary disease (COPD), sponsored by Xiangbei Welman Pharmaceuticals. Started Mar 2014; status: active.
02
Drugs
ceftazidime + sulbactam
03
Conditions
pneumoniaacute bronchitischronic bronchitis (CB)bronchiectasischronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on CTR20132859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132859.